glp 1 agonist comparison Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 Drug Comparison in Diabetes

Description

Vision changes GLP-1s can affect the vision in several ways, including worsening vision in some cases due to rapid blood sugar correction or insufficient blood flow to the optic nerve

Competing interests J.O

Preoperative fasting guidelines, such as those set by the American Society of Anesthesiologists (ASA), are designed to minimize the volume of residual gastric contents (Joshi et al

Semaglutide is a synthetic medication engineered in pharmaceutical laboratories to treat type 2 diabetes and obesity

In patients with obesity, GLP-1 RA therapy blunts the rise in ghrelin and other orexigenic gut peptides, thereby suppressing hunger ( As a result of these actions, GLP-1 RAs produce clinically meaningful weight loss